eli lilly zepbound weight loss news

Zepbound, Eli Lilly and obstructive sleep apnea

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

Reuters on MSN · 2d

Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder.

USA Today · 1d

Eli Lilly to test weight loss drug Zepbound to treat addiction

Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?

USA Today18d

Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial

Eli Lilly said on Wednesday patients ... JAMA Internal Medicine earlier this year showed Zepbound led to faster and greater weight loss than Wegovy. U.S.-based Lilly and Danish rival Novo ...

18d

Zepbound leads to more weight loss than Wegovy, Eli Lilly says

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Zepbound, Eli Lilly and obstructive sleep apnea

Trending now